85. Efficacy of Sulbactam-Durlobactam (SUL-DUR) Compared to Colistin (COL) against Acinetobacter baumannii-calcoaceticus Complex (ABC) Monomicrobial and Polymicrobial Infections in...

por Miller, Alita, McLeod, Sarah, Shapiro, Adam B, Rana, Khurram, Altarac, David
Publicado 2023

Correlation Between Peak Expiratory Flow Rate, Markers of Adiposity, and Anthropometric Measures in Medical Students in Pakistan

por Ijaz, Amna, Bashir, Imtiaz, Ikhlaq, Azal, Ijaz, Farhat, Aftab, Rana Khurram, Zia, Robass
Publicado 2020

COVID-19 pandemic and antimicrobial resistance in developing countries

por Arshad, Abdul Rehman, Ijaz, Farhat, Siddiqui, Mishal Shan, Khalid, Saad, Fatima, Abeer, Aftab, Rana Khurram
Publicado 2021

A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C

por Flisiak, Robert, Shiffman, Mitchell, Arenas, Juan, Cheinquer, Hugo, Nikitin, Igor, Dong, Yuping, Rana, Khurram, Srinivasan, Subasree
Publicado 2016

Role of Interleukin-10 and Abdominopelvic Ultrasound as a Potential Predictor of Disease Severity in Dengue Hemorrhagic Fever

por Tauseef, Ambreen, Ijaz, Farhat, Chaudhary, Farid Ahmad, Ali, Zaima, Akram, Tanzeela, Aftab, Rana Khurram, Ahmad, Gulfam
Publicado 2019

Is COVID-19 Fatality Rate Associated with Malaria Endemicity?

por Arshad, Abdul Rehman, Bashir, Imtiaz, Ijaz, Farhat, Loh, Nicholas, Shukla, Suraj, Rehman, Ubaid Ur, Aftab, Rana Khurram
Publicado 2020

820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b

por Brunetto, Maurizia, Rana, Khurram, Taliani, Gloria, Lawitz, Eric, Hézode, Christophe, Marcellin, Patrick, Serfaty, Lawrence, Cohen, David, Srinivasan, Subasree
Publicado 2014

1490. Serious Infections Caused by Carbapenem Susceptible and Carbapenem Resistant Acinetobacter baumannii-calcoaceticus Complex - A Retrospective Review

por Rana, Khurram, Wunderink, Richard G, Tsuei, Betty J, Rahav, Galia, Kovalchuk, Eugenii, Koksal, Iftihar, Maloney, Kathleen, Srinivasan, Subasree
Publicado 2020

Acute Adverse Effects of Vaccines Against SARS-COV-2

por Mahmood, Amina, Shujaat, Syeda Ayat, Hayat, Meryum, Ijaz, Farhat, Habib, Shanzay, Sadaqat, Waliya, Aftab, Rana Khurram, Inam, Syed Hashim Ali
Publicado 2022

All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study

por Nelson, David R, Cooper, James N, Lalezari, Jacob P, Lawitz, Eric, Pockros, Paul J, Gitlin, Norman, Freilich, Bradley F, Younes, Ziad H, Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J, Ortiz-Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M, Varunok, Peter, Kowdley, Kris V, Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A
Publicado 2015